Hormone replacement therapy and the increase in the incidence of invasive lobular cancer

Breast Disease

Volumn 30, Issue , 2008, Pages 3-8

  Ravdin, Peter M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE; PLACEBO;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; HORMONE SUBSTITUTION; HUMAN; INTRADUCTAL CARCINOMA; LOBULAR BREAST CANCER; MAMMOGRAPHY; META ANALYSIS; MONOTHERAPY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 70350755893     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2009-0283     Document Type: Article

References (14)

1. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.5.1., and Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2008 Sub (1973-2006).
2. C.I. Li, N.S. Weiss, J.L. Stanford and J.R. Daling, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer 88(11) (2000), 2570-2577.
3. C.I. Li, B.O. Anderson, P. Porter, S.K. Holt, J.R. Daling and R.E. Moe, Changing incidence rate of invasive lobular breast carcinoma among older women, Cancer 88(11) (2000), 2561-2569.
4. C.L. Chen, N.S. Weiss, P. Newcomb, W. Barlow and E. White, Hormone replacement therapy in relation to breast cancer, JAMA 287 6) (2002), 734-741.
5. J. Manjer, J. Malina, G. Berglund, L. Bondeson, J.P. Garne and L. Janzon, Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy, International Journal of Cancer 92(6) (2001), 919-922.
6. L.U. Rosenberg, C. Magusson, E. Lindstrom et al., Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: A case control study, Breast Cancer Res 8 (2006), R11.
7. P.A. Newcomb, L. Titus-Ernstoff, K.M. Egan, A. Trentham-Dietz, J.A. Baron, B.E. Storer, W.C. Willett and M.J. Stampfer, Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiol Biomarkers Prev 11 (2002), 593-600.
8. G. Ursin, C.C. Tseng, A. Paganini-Hill, S. Enger, P.C. Wan, S. Formenti, M.C. Pike and R.K. Ross, Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? Journal of Clinical Oncology 20(3) (2002), 699-706.
9. J.R. Daling, K.E. Malone, D.R. Doody, L.F. Voigt, L. Bernstein, R.J. Coates, P.A. Marchbanks, S.A. Norman, L.K. Weiss, G. Ursin, J.A. Berlin, R.T. Burkman, D. Deapen, S.G. Folger, J.A. McDonald, M.S. Simon, B.L. Strom, P.A. Wingo and R. Spirtas, Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma, Cancer 95(12) (2002), 2455-2464.
10. G.K. Reeves, V. Beral, J. Green, T. Gathani and D. Bull, Million Women Study Collaborators. Hormonal therapy for menopause and breast-cancer risk by histological type: A cohort study and meta-analysis, Lancet Oncology 7(11) (Nov 2006), 910-918.
11. A.G. Glass, J.V. Lacey Jr., J.D. Carreon and R.N. Hoover, Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status, Journal of the National Cancer Institute 99(15) (2007), 1152-1161.
12. Verkooijen, V.C. Koot, G. Fioretta and M. van der Heiden, Schipper ME Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: An ecological study comparing two European populations, Breast Cancer Research & Treatment 107(3) (2008), 389-395.
13. R.T. Chlebowski, S.L. Hendrix, R.D. Langer, M.L. Stefanick, M. Gass, D. Lane, R.J. Rodabough, M.A. Gilligan, M.G. Cyr, C.A. Thomson, J. Khandekar, H. Petrovitch and A. McTiernan, WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial, JAMA 289(24) (2003), 3243-3253.
14. M.L. Stefanick, G.L. Anderson, K.L. Margolis et al., Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy, JAMA 295 (2006), 1647-1657.